[Therapeutic targets in polyglutamine diseases]

Tanpakushitsu Kakusan Koso. 2004 May;49(7 Suppl):1118-21.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Adenosine Triphosphatases
  • Animals
  • Antineoplastic Agents / therapeutic use
  • Benzoquinones
  • Cell Cycle Proteins* / physiology
  • Congo Red / therapeutic use
  • Drug Delivery Systems*
  • Drug Design*
  • Endoplasmic Reticulum / metabolism
  • Histone Deacetylase Inhibitors
  • Humans
  • Hydroxamic Acids / therapeutic use
  • Lactams, Macrocyclic
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / genetics*
  • Peptides / metabolism*
  • Protein Processing, Post-Translational
  • Quinones / therapeutic use
  • RNA Interference
  • Valosin Containing Protein
  • Vorinostat

Substances

  • Antineoplastic Agents
  • Benzoquinones
  • Cell Cycle Proteins
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Lactams, Macrocyclic
  • Peptides
  • Quinones
  • polyglutamine
  • Congo Red
  • Vorinostat
  • Adenosine Triphosphatases
  • Valosin Containing Protein
  • geldanamycin